Investors See Reasons to Jump Into U.S. Markets

Related Link: 

A resurgent dollar is remaking the investment landscape as Fed stimulus ends, in a shift many fund managers expect will propel U.S. stocks, and even bonds, to fresh gains.

American Realty to Sell Private Capital Business to RCS

Related Link: 

American Realty Capital Properties Inc. said it has agreed to sell its private capital management business to RCS Capital Corp. for at least $700 million.

EU Says Apple, Fiat Tax Deals Broke Rules

Related Link: 

European Union regulators said they believe that tax deals granted to Apple in Ireland and Fiat in Luxembourg constitute illegal state support for the companies.

A Chinese Fracking Bet Goes Wrong

Related Link: 

The Bakken Shale formation has revolutionized North America's energy industry. But an early Chinese private-equity bet into Canada's side of the oil field has little to show for its investment.

The Man to Change How Wall Street Chats?

Related Link: 

David Gurle, who is on the cusp of a deal to sell his two-year-old instant-messaging company, Perzo Inc., to 15 of the world's largest banks and money managers, is no stranger on Wall Street.

'Made in USA' Spurs Lawsuits

Related Link: 

Chinese nets and bolts ensnare Lifetime Products' basketball hoops in litigation over whether they qualify for "Made in USA" labeling.

Citi Gets Reprieve on Hedge-Fund Curbs

Related Link: 

U.S. securities regulators granted Citigroup waivers that allow it to resume selling investments in hedge funds and private-equity funds to wealthy clients.

EBay to Spin Off PayPal Business

Related Link: 

Coming competition in paying for everyday purchases with smartphones, including an aggressive entry from Apple, pushed online retailer eBay to reverse course and set free its PayPal unit.

China's Bahamas Project Hits Hurdles

Related Link: 

China's largest overseas commercial real-estate project has been overshadowed by delays and labor clashes, dulling the buzz surrounding the Bahamian venture and threatening to undermine future business.

Doctors Net Billions From Drug Firms

Related Link: 

Drug and medical-device companies paid at least $3.5 billion to U.S. physicians and teaching hospitals during the final five months of last year.

Syndicate content